Skip to main content

The donor: Heather Douglas

The gift: Helping raise $314,000 and climbing

The cause: The Canadian Cancer Society

Story continues below advertisement

The reason: To fund research into breast cancer that has metastasized

When Heather Douglas was diagnosed with breast cancer in 2004, she had a mastectomy and felt confident the cancer had been caught early. Five years later, she discovered the cancer had metastasized, or spread, to the lining in her lungs and her liver.

Ms. Douglas, 51, eventually had to quit her job as a mining analyst and she recently moved from Calgary to Ottawa with her husband to be closer to her parents. The median life span for people with metastatic breast cancer is about three years. “I’m clearly on the lucky side of it,” she said.

A couple of years ago, Ms. Douglas decided to participate in the Run for the Cure, the Canadian Cancer Society’s annual fundraising event for breast cancer research. She found the event’s relentless focus on survivors unsettling and organizers discouraged talk about women who were living with metastatic breast cancer. And yet, up to 30 per cent of early-stage breast cancer patients see a recurrence of the disease and there’s little research into why that happens.

Ms. Douglas and a group of friends began organizing Metastatic Breast Cancer teams for the run and the Cancer Society has agreed that all money raised by the teams will be directed toward research into metastasized cancer. The number of teams across Canada has jumped from 10 in 2016 to 20 this year, and so far they have raised $314,000 in total. Ms. Douglas is hoping for more teams next year, although many team captains have died. Women with metastatic breast cancer “feel really isolated,” she said. “Now they can feel the strength of being together.”

pwaldie@globeandmail.com

Report an error Editorial code of conduct
Comments

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • All comments will be reviewed by one or more moderators before being posted to the site. This should only take a few moments.
  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

Comments that violate our community guidelines will be removed. Commenters who repeatedly violate community guidelines may be suspended, causing them to temporarily lose their ability to engage with comments.

Read our community guidelines here

Discussion loading ...

Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.
Cannabis pro newsletter